In episode 31, host David Willows invites returning pharmacy strategy guests Ned Pojskic (aka GSC’s “Outspoken Evangelist”) and super-pharmacist Leila Mandlsohn to discuss a topic near and dear to our hearts… Canada’s progress with biosimilar adoption. They discuss provincial drug plan movement, the ongoing (and curious) hesitancy from private payors, the patient experience, and the biosimilars pipeline.

And now for something completely indifferent

Episode 31: Back to Biosimilars… is Canada Finally Stepping Up?

In episode 30, host David Willows chats with returning guest Chris Bonnett, Principal Consultant at H3 Consulting, and first-time contributor Helen Stevenson, Founder and CEO of Reformulary Group, about (…to be blunt…) why the pharmacare debate never advances and what collaborative and practical approaches could help “fill the gaps” for Canadians without adequate drug coverage.

Episode 30: Pharmacare in 2021 – The Path to Meaningful Reform

In this episode, host David Willows once again interviews Dr. Carlos Quiñonez, associate professor and program director at the Faculty of Dentistry, University of Toronto. They re-visit the state of oral health care and talk about the Green Door Project – the largest-ever dental public health service and research program in Canadian history.

Episode 29: Addressing gaps in oral health care

In this episode, GSC’s David Willows interviews CLHIA president and CEO Stephen Frank to reminisce about 2020 and forecast what 2021 will bring, namely a possible federal election, the pharmacare debate revisited and more Covid-19.

Episode 28: On the air with Stephen Frank – 2020 Year in Review and 2021 Forecast

In episode 27, we invite GSC’s Ned Pojskic and Mike Sullivan of Cubic Health Inc. to kick off 2021 with a look at where MC has been and where it might be headed.

Episode 27: Don’t Believe the Hype – How Medical Cannabis Flopped

In episode 26 of GSC’s podcast, we bring back pharmacist and researcher John Papastergiou, as well as Ned Pojskic, GSC’s leader of pharmacy and health provider relations, to talk about their research project that studied the impact of pharmacogenomics testing on patient outcomes.

Episode 26: Pharmacogenomics – First Evidence to Action

In episode 25, host David Willows and producer Sarah Murphy chat with two guests (virtually) to talk about pharmacare – Chris Bonnett, Principal Consultant at H3 Consulting (and recent PhD recipient) and regular contributor Stephen Frank, CLHIA President and CEO.

Episode 25: Pharmacare revisited...

In episode 24, host David Willows and producer Sarah Murphy invite Dr. Carlos Quinonez to the podcast studio to talk about the state of dentistry in Canada in 2020 and how it impacts benefits plans.

Episode 24: The state of dentistry in Canada

In episode 23, host David Willows and producer Sarah Murphy bring back GSC writer Carley Parekh to discuss her latest edition of g(sc) TALK, which offers some practical (and evidence-based) advice on how to best adjust to pandemic life.

Episode 23: Life in the time of COVID-19

In episode 22, host David Willows and producer Sarah Murphy bring back GSC writer Carley Parekh to discuss her recent edition of g(sc) TALK which takes a critical look at the world of diets and diet culture.

Episode 22: The diet dilemma

In episode 21, producer Sarah Murphy and host David Willows welcome (for the third time) CLHIA’s President and CEO Stephen Frank to talk about industry happenings – pharmacare, CCIR, fraud, and more.

Episode 21: On air with Stephen Frank, again

In episode 20, producer Sarah Murphy and host David Willows welcome back GSC writer Carley Parekh to the podcast studio to share the research behind her “Gut feelings” article in (g)sc TALK.

Episode 20: All About Gut Stuff

In Episode 19, producer Sarah Murphy and host David Willows welcome Dr. Danielle Martin to the podcast studio to discuss better approaches to health care.

Episode 19: Medicalization of healthy people

In episode 18, producer Sarah Murphy and host David Willows welcome GSC writer Carley Parekh to the podcast studio to share the research behind her “Health by the numbers” article in (g)sc TALK.

Episode 18: Health by the numbers

In episode 17, producer Sarah Murphy and host David Willows welcome special guest Dr. Luca Pani from the University of Miami and Ned Pojskic, GSC’s leader of pharmacy & health provider relations, to discuss the promise and challenging financial impact of gene therapy.

Episode 17: The promise and impact of gene therapy

Welcome to “And now for something completely indifferent® ”, a Canadian health benefits industry podcast, brought to you by your friends at Green Shield Canada (GSC).

hubhopper

And now for something completely indifferent

hubhopper